Cargando…
Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castrationresistant prostate cancer: a report from the PETRUS prospective study
Molecular characterization of cancer samples is hampered by tumor tissue availability in metastatic castration-resistant prostate cancer (mCRPC) patients. We reported the results of prospective PETRUS study of biomarker assessment in paired primary prostatic tumors, metastatic biopsies and circulati...
Autores principales: | Massard, Christophe, Oulhen, Marianne, Le Moulec, Sylvestre, Auger, Nathalie, Foulon, Stéphanie, Abou-Lovergne, Aurélie, Billiot, Fanny, Valent, Alexander, Marty, Virginie, Loriot, Yohann, Fizazi, Karim, Vielh, Philippe, Farace, Francoise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342402/ https://www.ncbi.nlm.nih.gov/pubmed/27391263 http://dx.doi.org/10.18632/oncotarget.10396 |
Ejemplares similares
-
Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer
por: Lindsay, C. R., et al.
Publicado: (2016) -
Method for semi-automated microscopy of filtration-enriched circulating tumor cells
por: Pailler, Emma, et al.
Publicado: (2016) -
A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas
por: Farace, F, et al.
Publicado: (2011) -
Petrus Hispanus
Publicado: (1924) -
ODM-201: a new-generation androgen receptor inhibitor in castration-resistant prostate cancer
por: Fizazi, Karim, et al.
Publicado: (2015)